Institut de Cancérologie de Lorraine

The Institut de Cancérologie de Lorraine (ICL) is a premier comprehensive cancer center based in Vandœuvre-lès-Nancy, France, and a prominent member of the Unicancer network. Operating as a private non-profit hospital of collective interest (ESPIC), ICL integrates high-level clinical care with cutting-edge oncological research and medical education. The institute is equipped with advanced facilities for radiotherapy, nuclear medicine, and specialized oncological surgery, serving thousands of patients annually. ICL maintains a significant clinical research footprint, coordinating and participating in numerous Phase 1 through Phase 3 clinical trials across various solid tumor indications. Its research efforts are particularly focused on personalized medicine, radiomics, and the optimization of therapeutic strategies to improve patient outcomes.